{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:32:48Z","timestamp":1790839968651,"version":"4.1.0"},"reference-count":161,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mitochondrion"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.mito.2017.10.003","type":"journal-article","created":{"date-parts":[[2017,10,18]],"date-time":"2017-10-18T14:50:40Z","timestamp":1508338240000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Mitochondrial disorders of the retinal ganglion cells and the optic nerve"],"prefix":"10.1016","volume":"42","author":[{"given":"Josef","family":"Finsterer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelangelo","family":"Mancuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Pareyson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5874-9204","authenticated-orcid":false,"given":"Jean-Marc","family":"Burgunder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Klopstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mito.2017.10.003_bb0005","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/ng.3354","article-title":"Mutations in SLC25A46, encoding a UGO1-like protein, cause an optic atrophy spectrum disorder","volume":"47","author":"Abrams","year":"2015","journal-title":"Nat. Genet."},{"issue":"8","key":"10.1016\/j.mito.2017.10.003_bb0010","doi-asserted-by":"crossref","first-page":"e42242","DOI":"10.1371\/journal.pone.0042242","article-title":"Rare primary mitochondrial DNA mutations and probable synergistic variants in Leber's hereditary optic neuropathy","volume":"7","author":"Achilli","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.mito.2017.10.003_bb0015","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1007\/s00415-015-7849-6","article-title":"A novel OPA1 mutation causing variable age of onset autosomal dominant optic atrophy plus in an Australian family","volume":"262","author":"Ahmad","year":"2015","journal-title":"J. Neurol."},{"key":"10.1016\/j.mito.2017.10.003_bb0020","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1212\/WNL.0000000000000716","article-title":"Mitochondrial EFTs defects in juvenile-onset Leigh disease, ataxia, neuropathy, and optic atrophy","volume":"83","author":"Ahola","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.mito.2017.10.003_bb0025","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s13023-014-0190-9","article-title":"Expanding the phenotype of PRPS1 syndromes in females: neuropathy, hearing loss and retinopathy","volume":"9","author":"Almoguera","year":"2014","journal-title":"Orphanet. J. Rare Dis."},{"key":"10.1016\/j.mito.2017.10.003_bb0030","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/brain\/awm298","article-title":"OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes","volume":"131","author":"Amati-Bonneau","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.mito.2017.10.003_bb0035","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1186\/1756-0500-4-557","article-title":"Idebenone increases mitochondrial complex I activity in fibroblasts from LHON patients while producing contradictory effects on respiration","volume":"4","author":"Angebault","year":"2011","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.mito.2017.10.003_bb0040","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.ajhg.2015.09.012","article-title":"Recessive mutations in RTN4IP1 cause isolated and syndromic optic neuropathies","volume":"97","author":"Angebault","year":"2015","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.mito.2017.10.003_bb0045","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000339310","article-title":"OPA3\u2014related autosomal dominant optic atrophy and cataract with ataxia and areflexia","volume":"68","author":"Ayrignac","year":"2012","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.mito.2017.10.003_bb0050","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/sj.ejhg.5201070","article-title":"A first locus for isolated autosomal recessive opticatrophy(ROA1) maps to chromosome 8q","volume":"11","author":"Barbet","year":"2003","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.mito.2017.10.003_bb0055","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1136\/jmg.2004.025502","article-title":"A third locus for dominant optic atrophy on chromosome 22q","volume":"42","author":"Barbet","year":"2005","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.mito.2017.10.003_bb0060","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.ophtha.2009.12.042","article-title":"OPA1 mutations associated with dominant optic atrophy influence optic nerve head size","volume":"117","author":"Barboni","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.mito.2017.10.003_bb0065","doi-asserted-by":"crossref","first-page":"985","DOI":"10.5301\/ejo.5000154","article-title":"Retinal nerve fiber layer thickness variability in Leber hereditary optic neuropathy carriers","volume":"22","author":"Barboni","year":"2012","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.mito.2017.10.003_bb0070","doi-asserted-by":"crossref","first-page":"e231","DOI":"10.1093\/brain\/aws280","article-title":"Idebenone treatment in patients with OPA1-mutant dominant optic atrophy","volume":"136","author":"Barboni","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.mito.2017.10.003_bb0075","first-page":"1","article-title":"Oculomotor apraxia and dilated cardiomyopathy with ataxia syndrome: a case report","author":"Benson","year":"2016","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.mito.2017.10.003_bb0080","first-page":"3087","article-title":"Complete mitochondrial DNA genome sequence variation of Chinese families with mutation m.3635G>A and Leber hereditary optic neuropathy","volume":"18","author":"Bi","year":"2012","journal-title":"Mol. Vis."},{"key":"10.1016\/j.mito.2017.10.003_bb0085","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.bbamcr.2008.04.018","article-title":"The optimized allotopic expression of ND1 or ND4 genes restores respiratory chain complex I activity in fibroblasts harboring mutations in these genes","volume":"1783","author":"Bonnet","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mito.2017.10.003_bb0090","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.bbadis.2012.12.002","article-title":"Cybrid studies establish the causal link between the mtDNA m.3890G>A\/MT-ND1 mutation and optic atrophy with bilateral brainstem lesions","volume":"1832","author":"Caporali","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mito.2017.10.003_bb0095","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.preteyeres.2003.10.003","article-title":"Mitochondrial dysfunction as a cause of optic neuropathies","volume":"23","author":"Carelli","year":"2004","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.mito.2017.10.003_bb0100","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1093\/hmg\/ddr071","article-title":"A clinically complex form of dominant optic atrophy (OPA8) maps on chromosome 16","volume":"20","author":"Carelli","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mito.2017.10.003_bb0105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ana.24410","article-title":"Syndromic parkinsonism and dementia associated with OPA1 missense mutations","volume":"78","author":"Carelli","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.mito.2017.10.003_bb0110","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/jns.12117","article-title":"MFN2 deletion of exons 7 and 8: founder mutation in the UK population","volume":"20","author":"Carr","year":"2015","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.mito.2017.10.003_bb0115","first-page":"1026","article-title":"Multiple symmetric lipomatosis associated to polyneuropathology, atrophy of the cerebellum and mitochondrial cytopathy","volume":"36","author":"Castro-Gago","year":"2003","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.mito.2017.10.003_bb0120","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1002\/ajmg.a.37188","article-title":"Optic neuropathy, cardiomyopathy, cognitive disability in patients with a homozygous mutation in the nuclear MTO1 and a mitochondrial MT-TF variant","volume":"167A","author":"Charif","year":"2015","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.mito.2017.10.003_bb0125","first-page":"292","article-title":"Mutation survey of the optic atrophy 1 gene in 193 Chinese families with suspected hereditary optic neuropathy","volume":"19","author":"Chen","year":"2013","journal-title":"Mol. Vis."},{"key":"10.1016\/j.mito.2017.10.003_bb0130","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/ana.21376","article-title":"Reversible optic neuropathy with OPA1 exon 5b mutation","volume":"63","author":"Cornille","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.mito.2017.10.003_bb0135","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/WNO.0b013e31828f8d75","article-title":"Posterior reversible encephalopathy syndrome in a leber hereditary optic neuropathy patient with mitochondrial DNA 11778G>A point mutation","volume":"33","author":"Da","year":"2013","journal-title":"J. Neuroophthalmol."},{"key":"10.1016\/j.mito.2017.10.003_bb0140","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3129\/i10-077","article-title":"Current approaches and future prospects for stem cell rescue and regeneration of the retina and optic nerve","volume":"45","author":"Dahlmann-Noor","year":"2010","journal-title":"Can. J. Ophthalmol."},{"key":"10.1016\/j.mito.2017.10.003_bb0145","first-page":"1849","article-title":"TMEM126A mutation in a Moroccan family with autosomal recessive optic atrophy","volume":"18","author":"D\u00e9sir","year":"2012","journal-title":"Mol. Vis."},{"key":"10.1016\/j.mito.2017.10.003_bb0150","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.braindev.2015.11.006","article-title":"Clinical and allelic heterogeneity in a pediatric cohort of 11 patients carrying MFN2 mutation","volume":"38","author":"Di Meglio","year":"2016","journal-title":"Brain and Development"},{"key":"10.1016\/j.mito.2017.10.003_bb0155","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1136\/jmg.2005.034892","article-title":"Autosomal dominant optic atrophy associated with hearing impairment and impaired glucose regulation caused by a missense mutation in the WFS1 gene","volume":"43","author":"Eiberg","year":"2006","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.mito.2017.10.003_bb0160","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1101\/gr.108696.110","article-title":"OPA1 links human mitochondrial genome maintenance to mtDNA replication and distribution","volume":"21","author":"Elachouri","year":"2011","journal-title":"Genome Res."},{"key":"10.1016\/j.mito.2017.10.003_bb0165","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ajhg.2008.08.013","article-title":"Optimized allotopic expression of the human mitochondrial ND4 prevents blindness in a rat model of mitochondrial dysfunction","volume":"83","author":"Ellouze","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.mito.2017.10.003_bb0170","doi-asserted-by":"crossref","first-page":"E692","DOI":"10.1002\/humu.21025","article-title":"Molecular screening of 980 cases of suspected hereditary optic neuropathy with a report on 77 novel OPA1 mutations","volume":"30","author":"Ferre","year":"2009","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.mito.2017.10.003_bb0175","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ophtha.2015.10.025","article-title":"Gene therapy for Leber hereditary optic neuropathy: initial results","volume":"123","author":"Feuer","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.mito.2017.10.003_bb0180","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0887-8994(01)00377-0","article-title":"Mitochondrial DNA depletion in Leigh syndrome","volume":"26","author":"Filiano","year":"2002","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.mito.2017.10.003_bb0185","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.pediatrneurol.2014.06.023","article-title":"Therapeutic strategies for mitochondrial disorders","volume":"52","author":"Finsterer","year":"2015","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.mito.2017.10.003_bb0190","doi-asserted-by":"crossref","first-page":"122","DOI":"10.11622\/smedj.2015026","article-title":"Glucocorticoids for mitochondrial disorders","volume":"56","author":"Finsterer","year":"2015","journal-title":"Singap. Med. J."},{"key":"10.1016\/j.mito.2017.10.003_bb0195","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4330\/wjc.v8.i5.333","article-title":"Mitochondrial vasculopathy","volume":"8","author":"Finsterer","year":"2016","journal-title":"World J. Cardiol."},{"key":"10.1016\/j.mito.2017.10.003_bb0200","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.18295\/squmj.2016.16.01.017","article-title":"Mitochondrial disorders may mimic amyotrophic lateral sclerosis at onset","volume":"16","author":"Finsterer","year":"2016","journal-title":"Sultan Qaboos Univ. Med. J."},{"key":"10.1016\/j.mito.2017.10.003_bb0205","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/j.1468-1331.2009.02811.x","article-title":"European Federation of Neurological Sciences. EFNS guidelines on the molecular diagnosis of mitochondrial disorders","volume":"16","author":"Finsterer","year":"2009","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.mito.2017.10.003_bb0210","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1177\/0883073815599263","article-title":"The eye on mitochondrial disorders","volume":"31","author":"Finsterer","year":"2016","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.mito.2017.10.003_bb0215","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.survophthal.2009.10.002","article-title":"The Neuroophthalmology of mitochondrial disease","volume":"55","author":"Fraser","year":"2010","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.mito.2017.10.003_bb0220","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.bbadis.2016.10.028","article-title":"The addition of ketone bodies alleviates mitochondrial dysfunction by restoring complex I assembly in a MELAS cellular model","volume":"1863","author":"Frey","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mito.2017.10.003_bb0225","first-page":"485","article-title":"Novel mutation T8821G in mitochondrial DNA may be associated with Leber's hereditary optic neuropathy","volume":"32","author":"Gao","year":"2015","journal-title":"Zhonghua Yi Xue Yi Chuan Xue Za Zhi"},{"key":"10.1016\/j.mito.2017.10.003_bb0230","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s10545-011-9413-6","article-title":"Further delineation of pontocerebellar hypoplasia type 6 due to mutations in the gene encoding mitochondrial arginyl-tRNA synthetase, RARS2","volume":"35","author":"Glamuzina","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.mito.2017.10.003_bb0235","doi-asserted-by":"crossref","first-page":"16080","DOI":"10.1038\/nrdp.2016.80","article-title":"Mitochondrial diseases","volume":"2","author":"Gorman","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.mito.2017.10.003_bb0240","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1136\/jmedgenet-2013-101774","article-title":"A novel heterozygous OPA3 mutation located in the mitochondrial target sequence results in altered steady-state levels and fragmented mitochondrial network","volume":"50","author":"Grau","year":"2013","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.mito.2017.10.003_bb0245","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.ophtha.2016.05.036","article-title":"WFS1 in optic neuropathies: mutation findings in nonsyndromic optic atrophy and assessment of clinical severity","volume":"123","author":"Grenier","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.mito.2017.10.003_bb0250","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/112067219200200104","article-title":"Kearns-Sayre syndrome: a case report and review","volume":"2","author":"Gross-Jendroska","year":"1992","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.mito.2017.10.003_bb0255","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1167\/iovs.08-3214","article-title":"Efficiency and safety of AAV-mediated gene delivery of the human ND4 complex I subunit in the mouse visual system","volume":"50","author":"Guy","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.mito.2017.10.003_bb0260","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1167\/iovs.13-13365","article-title":"Retinal ganglion cell dysfunction in asymptomatic G11778A: Leber hereditary optic neuropathy","volume":"55","author":"Guy","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.mito.2017.10.003_bb0265","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/mds.25033","article-title":"The phenotypic spectrum of dystonia in Mohr-Tranebjaerg syndrome","volume":"27","author":"Ha","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.mito.2017.10.003_bb0270","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/j.jocn.2014.03.020","article-title":"Adult onset Leigh syndrome with mitochondrial DNA 8344 A>G mutation","volume":"21","author":"Han","year":"2014","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.mito.2017.10.003_bb0275","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/bjophthalmol-2014-305704","article-title":"Ophthalmological manifestations in patients with Leigh syndrome","volume":"99","author":"Han","year":"2015","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.mito.2017.10.003_bb0280","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ajhg.2009.03.003","article-title":"TMEM126A, encoding mitochondrial protein,is mutated in autosomal-recessive non syn- dromic optic atrophy","volume":"84","author":"Hanein","year":"2009","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.mito.2017.10.003_bb0285","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/humu.23060","article-title":"Novel genetic, clinical, and pathomechanistic insights into TFG-Associated hereditary spastic paraplegia","volume":"37","author":"Harlalka","year":"2016","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.mito.2017.10.003_bb0290","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ajhg.2011.09.007","article-title":"Absence of an orphan mitochondrial protein, c19orf12, causes a distinct clinical subtype of neurodegeneration with brain iron accumulation","volume":"89","author":"Hartig","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.mito.2017.10.003_bb0295","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/WNO.0000000000000076","article-title":"Optic atrophy and a Leigh-like syndrome due to mutations in the c12orf65 gene: report of a novel mutation and review of the literature","volume":"34","author":"Heidary","year":"2014","journal-title":"J. Neuroophthalmol."},{"key":"10.1016\/j.mito.2017.10.003_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajhg.2016.09.021","article-title":"MECR mutations cause childhood-onset dystonia and optic atrophy, a mitochondrial fatty acid synthesis disorder","author":"Heimer","year":"2016","journal-title":"Am. J. Hum. Genet."},{"issue":"9","key":"10.1016\/j.mito.2017.10.003_bb0305","doi-asserted-by":"crossref","first-page":"e45182","DOI":"10.1371\/journal.pone.0045182","article-title":"Idebenone protects against retinal damage and loss of vision in a mouse model of Leber's hereditary optic neuropathy","volume":"7","author":"Heitz","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.mito.2017.10.003_bb0310","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/A:1001844021014","article-title":"Electrophysiological findings in dominant optic atrophy (DOA) linking to the OPA1 locus on chromosome 3q 28-qter","volume":"95","author":"Holder","year":"1998","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.mito.2017.10.003_bb0315","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2012-007272","article-title":"Kearns-Sayre syndrome presenting as isolated growth failure","author":"Holloman","year":"2013","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.mito.2017.10.003_bb0320","first-page":"294","article-title":"Hyperintense optic nerve lesion on T2-weighted MRI imaging in the acute stage of Leber's hereditary optic neuropathy: a case report","volume":"46","author":"Honda","year":"2006","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.mito.2017.10.003_bb0325","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3109\/13816810.2010.531880","article-title":"Central retinal vein occlusion as the initial manifestation of LHON\/MELAS overlap syndrome with mitochondrial DNA G13513A mutation\u2014case report and literature review","volume":"32","author":"Hsieh","year":"2011","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.mito.2017.10.003_bb0330","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/brain\/awm272","article-title":"Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance","volume":"131","author":"Hudson","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.mito.2017.10.003_bb0335","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/13816819709057122","article-title":"Optic neuropathy associated with mitochondrial tRNALeu(UUR) A3243G mutation","volume":"18","author":"Hwang","year":"1997","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.mito.2017.10.003_bb0340","first-page":"212","article-title":"Homozygous p.V116* mutation in C12orf65 results in Leigh syndrome","volume":"87","author":"Imagawa","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.mito.2017.10.003_bb0345","doi-asserted-by":"crossref","DOI":"10.1111\/aos.12999","article-title":"The reduction of temporal optic nerve head microcirculation in autosomal dominant optic atrophy","author":"Inoue","year":"2016","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.mito.2017.10.003_bb0350","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.ajhg.2008.11.002","article-title":"Mitochondrial DNA haplogroups M7b1'2 and M8a affect clinical expression of leber hereditary optic neuropathy in Chinese families with the m.11778G>A mutation","volume":"83","author":"Ji","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.mito.2017.10.003_bb0355","doi-asserted-by":"crossref","first-page":"10961","DOI":"10.4238\/2015.September.21.8","article-title":"Identification of copy number variation in the gene for autosomal dominant optic atrophy, OPA1, in a Chinese pedigree","volume":"14","author":"Jin","year":"2015","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.mito.2017.10.003_bb0360","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1167\/iovs.14-16288","article-title":"Changes in mitochondrial morphology and bioenergetics in human lymphoblastoid cells with four novel OPA1 mutations","volume":"56","author":"Kao","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.mito.2017.10.003_bb0365","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1002\/ajmg.a.31455","article-title":"A family with X-linked optic atrophy linked to the OPA2 locus Xp11.4-Xp11.2","volume":"140","author":"Katz","year":"2006","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.mito.2017.10.003_bb0370","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1001\/archopht.117.6.805","article-title":"Genetic heterogeneity of dominant optic atrophy, Kjer type: Identification of a second locus on chromosome 18q12.2-12.3","volume":"117","author":"Kerrison","year":"1999","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.mito.2017.10.003_bb0375","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1167\/iovs.16-20695","article-title":"Leber's hereditary optic Neuropathy-Specific mutation m.11778G>A exists on diverse mitochondrial haplogroups in India","volume":"58","author":"Khan","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.mito.2017.10.003_bb0380","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3346\/jkms.2010.25.1.180","article-title":"Pediatric-onset dystonia associated with bilateral striatal necrosis and G14459A mutation in a Korean family: a case report","volume":"25","author":"Kim","year":"2010","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.mito.2017.10.003_bb0385","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jns.2015.07.009","article-title":"Behr syndrome with homozygous C19ORF12 mutation","volume":"357","author":"Kleffner","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.mito.2017.10.003_bb0390","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1093\/brain\/awr170","article-title":"A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy","volume":"134","author":"Klopstock","year":"2011","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.mito.2017.10.003_bb0395","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13073-016-0380-2","article-title":"Mitochondrial replacement approaches: challenges for clinical implementation","volume":"8","author":"Klopstock","year":"2016","journal-title":"Genome Med."},{"key":"10.1016\/j.mito.2017.10.003_bb0400","first-page":"1","article-title":"Unique presentation of LHON\/MELAS overlap syndrome caused by m.13046T>C in MTND5","author":"Kolarova","year":"2016","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.mito.2017.10.003_bb0405","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1093\/brain\/awq155","article-title":"Melanopsin retinal ganglion cells are resistant to neurode-generation in mitochondrial optic neuropathies","volume":"133","author":"La Morgia","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.mito.2017.10.003_bb0410","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3389\/fneur.2014.00141","article-title":"Medical management of hereditary optic neuropathies","volume":"5","author":"La Morgia","year":"2014","journal-title":"Front. Neurol."},{"key":"10.1016\/j.mito.2017.10.003_bb0415","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1471-2377-14-116","article-title":"Association of the mtDNA m.4171C>A\/MT-ND1 mutation with both optic neuropathy and bilateral brainstem lesions","volume":"14","author":"La Morgia","year":"2014","journal-title":"BMC Neurol."},{"key":"10.1016\/j.mito.2017.10.003_bb0420","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jns.2016.09.046","article-title":"Retinal and optic nerve abnormalities in neurodegeneration associated with mutations in C19orf12 (MPAN)","volume":"370","author":"Langwinska-Wosko","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.mito.2017.10.003_bb0425","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3892\/mmr.2016.5209","article-title":"Recessive optic atrophy, sensorimotor neuropathy and cataract associated with novel compound heterozygous mutations in OPA1","volume":"14","author":"Lee","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.mito.2017.10.003_bb0435","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.neurol.2014.03.009","article-title":"Mitochondrial dysfunction affecting visual pathways","volume":"170","author":"Leruez","year":"2014","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/j.mito.2017.10.003_bb0440","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1177\/0883073810384615","article-title":"Juvenile Leigh syndrome, optic atrophy, ataxia, dystonia, and epilepsy due to T14487C mutation in the mtDNA-ND6 gene: a mitochondrial syndrome presenting from birth to adolescence","volume":"26","author":"Leshinsky-Silver","year":"2011","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.mito.2017.10.003_bb0445","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1212\/WNL.0000000000003491","article-title":"Dysregulated mitophagy and mitochondrial organization in optic atrophy due to OPA1 mutations","volume":"88","author":"Liao","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.mito.2017.10.003_bb0450","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2350-13-3","article-title":"Atypical case of Wolfram syndrome revealed through targeted exome sequencing in a patient with suspected mitochondrial disease","volume":"13","author":"Lieber","year":"2012","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.mito.2017.10.003_bb0455","doi-asserted-by":"crossref","first-page":"e225","DOI":"10.1111\/aos.12038","article-title":"Novel OPA1 missense mutation in a family with optic atrophy and severe widespread neurological disorder","volume":"91","author":"Liskova","year":"2013","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.mito.2017.10.003_bb0460","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1203\/00006450-199505000-00014","article-title":"Correlation between the clinical symptoms and the proportion of mitochondrial DNA carrying the 8993 point mutation in the NARP syndrome","volume":"37","author":"M\u00e4kel\u00e4-Bengs","year":"1995","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.mito.2017.10.003_bb0465","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1212\/WNL.0b013e318294b44c","article-title":"Phenotypic heterogeneity of the 8344A>G mtDNA \u201cMERRF\u201d mutation","volume":"80","author":"Mancuso","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.mito.2017.10.003_bb0470","first-page":"564","article-title":"A case of mitochondrial myopathy with external ophthalmoplegia and ataxic neuropathy","volume":"43","author":"Mano","year":"2003","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.mito.2017.10.003_bb0475","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1172\/JCI42951","article-title":"Stemming vision loss with stem cells","volume":"120","author":"Marchetti","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"90","key":"10.1016\/j.mito.2017.10.003_bb0480","article-title":"DNA methyltransferase 1 mutations and mitochondrial pathology: is mtDNA methylated?","volume":"6","author":"Maresca","year":"2015","journal-title":"Front. Genet."},{"key":"10.1016\/j.mito.2017.10.003_bb0485","article-title":"The homozygous R504C mutation in MTO1 gene is responsible for ONCE syndrome","author":"Mart\u00edn","year":"2016","journal-title":"Clin. Genet."},{"key":"10.1016\/j.mito.2017.10.003_bb0490","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/ceo.12355","article-title":"New MT-ND1 pathologic mutation for Leber hereditary optic neuropathy","volume":"42","author":"Mart\u00ednez-Romero","year":"2014","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.mito.2017.10.003_bb0495","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/00041327-200020030-00006","article-title":"Do idebenone and vitamin therapy shorten the time to achieve visual recovery in Leber hereditary optic neuropathy?","volume":"20","author":"Mashima","year":"2000","journal-title":"J. Neuroophthalmol."},{"key":"10.1016\/j.mito.2017.10.003_bb0500","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1136\/jmedgenet-2014-102532","article-title":"Mutations in the tricarboxylic acid cycle enzyme, aconitase 2, cause either isolated or syndromic optic neuropathy with encephalopathy and cerebellar atrophy","volume":"51","author":"Metodiev","year":"2014","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.mito.2017.10.003_bb0505","first-page":"650","article-title":"Nonsense mutation in TMEM126A causing autosomal recessive optic atrophy and auditory neuropathy","volume":"16","author":"Meyer","year":"2010","journal-title":"Mol. Vis."},{"key":"10.1016\/j.mito.2017.10.003_bb0510","first-page":"1165","article-title":"Leber hereditary optic neuropathy: current perspectives","volume":"9","author":"Meyerson","year":"2015","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.mito.2017.10.003_bb0515","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1001\/archneurol.2011.124","article-title":"Novel POLG splice site mutation and optic atrophy","volume":"68","author":"Milone","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.mito.2017.10.003_bb0520","author":"MITOMAP"},{"key":"10.1016\/j.mito.2017.10.003_bb0525","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jns.2010.03.014","article-title":"Vestibular dysfunction in a Japanese patient with a mutation in the gene OPA1","volume":"293","author":"Mizutari","year":"2010","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.mito.2017.10.003_bb0530","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/jnnp.58.1.70","article-title":"Bilateral simultaneous optic neuropathy in adults: clinical, imaging, serological, and genetic studies","volume":"58","author":"Morrissey","year":"1995","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.mito.2017.10.003_bb0535","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ajo.2005.03.017","article-title":"Hereditary opticneuropathies: from the mitochondria to the optic nerve","volume":"140","author":"Newman","year":"2005","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.mito.2017.10.003_bb0540","article-title":"Novel pathogenic SLC25A46 splice-site mutation causes an optic atrophy spectrum disorder","author":"Nguyen","year":"2016","journal-title":"Clin. Genet."},{"key":"10.1016\/j.mito.2017.10.003_bb0545","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00417-014-2852-7","article-title":"Optical coherence tomography shows early loss of the inferior temporal quadrant retinal nerve fiber layer in autosomal dominant optic atrophy","volume":"253","author":"Park","year":"2015","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.mito.2017.10.003_bb0550","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ejpn.2015.12.016","article-title":"Pontocerebellar hypoplasia type 2D and optic nerve atrophy further expand the spectrum associated with selenoprotein biosynthesis deficiency","volume":"20","author":"Pavlidou","year":"2016","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"2","key":"10.1016\/j.mito.2017.10.003_bb0555","doi-asserted-by":"crossref","first-page":"e56350","DOI":"10.1371\/journal.pone.0056350","article-title":"Non-image-forming light driven functions are preserved in a mouse model of autosomal dominant optic atrophy","volume":"8","author":"Perganta","year":"2013","journal-title":"PLoS One"},{"issue":"24","key":"10.1016\/j.mito.2017.10.003_bb0560","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1212\/01.wnl.0000437308.22603.43","article-title":"Clinical features of MS associated with Leber hereditary optic neuropathy mtDNA mutations","volume":"81","author":"Pfeffer","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.mito.2017.10.003_bb0565","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/1531-8249(199912)46:6<916::AID-ANA16>3.0.CO;2-R","article-title":"The mitochondrial DNA G13513A transition in ND5 is associated with a LHON\/MELAS overlap syndrome and may be a frequent cause of MELAS","volume":"46","author":"Pulkes","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.mito.2017.10.003_bb0570","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1600-0420.2005.00448.x","article-title":"Dominant optic atrophy: correlation between clinical and molecular genetic studies","volume":"83","author":"Puomila","year":"2005","journal-title":"Acta Ophthalmol. Scand."},{"key":"10.1016\/j.mito.2017.10.003_bb0575","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1001\/archopht.125.2.268","article-title":"Use of mitochondrial antioxidant defenses for rescue of cells with a Leber hereditary optic neuropathy-causing mutation","volume":"125","author":"Qi","year":"2007","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.mito.2017.10.003_bb0580","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1167\/iovs.08-2695","article-title":"Association of optic disc size with development and prognosis of Leber's hereditary optic neuropathy","volume":"50","author":"Ramos","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.mito.2017.10.003_bb0585","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1002\/ajmg.a.36766","article-title":"Deficiency in a patient with phenotypic characteristics of mitochondrial disorders","volume":"164A","author":"Reuter","year":"2014","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.mito.2017.10.003_bb0590","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/brain\/118.2.319","article-title":"The clinical features of Leber\u2019s hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation","volume":"118","author":"Riordan-Eva","year":"1995","journal-title":"Brain"},{"key":"10.1016\/j.mito.2017.10.003_bb0595","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jns.2015.01.008","article-title":"Neuroradiological findings expand the phenotype of OPA1-related mitochondrial dysfunction","volume":"349","author":"Roubertie","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.mito.2017.10.003_bb0600","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/WNO.0b013e318272c643","article-title":"Effects of idebenone on color vision in patients with Leber hereditary optic neuropathy","volume":"33","author":"Rudolph","year":"2013","journal-title":"J. Neuroophthalmol."},{"key":"10.1016\/j.mito.2017.10.003_bb0605","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10633-010-9241-2","article-title":"Visual evoked potentials findings in non-affected subjects from a large Brazilian pedigree of 11778 Leber's hereditary optic neuropathy","volume":"121","author":"Sacai","year":"2010","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.mito.2017.10.003_bb0610","first-page":"51","article-title":"Subclinical carriers and conversions in Leber hereditary optic neuropathy: a prospective psychophysical study","volume":"104","author":"Sadun","year":"2006","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"10.1016\/j.mito.2017.10.003_bb0615","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/brain\/aws303","article-title":"The human OPA1(delTTAG) mutation induces premature age-related systemic neurodegeneration in mouse","volume":"135","author":"Sarzi","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.mito.2017.10.003_bb0620","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddw117","article-title":"Increased steroidogenesis promotes early-onset and severe vision loss in females with OPA1 dominant optic atrophy","author":"Sarzi","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mito.2017.10.003_bb0625","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10048-014-0416-y","article-title":"Clinical and molecular genetic findings in autosomal dominant OPA3-related optic neuropathy","volume":"16","author":"Sergouniotis","year":"2015","journal-title":"Neurogenetics"},{"key":"10.1016\/j.mito.2017.10.003_bb0630","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neuroscience.2016.01.042","article-title":"A randomized, placebo-controlled trial of the benzoquinone idebenone in a mouse model of OPA1-related dominant optic atrophy reveals a limited therapeutic effect on retinal ganglion cell dendropathy and visual function","volume":"319","author":"Smith","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.mito.2017.10.003_bb0635","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/jmedgenet-2015-103361","article-title":"Fatal infantile mitochondrial encephalomyopathy, hypertrophic cardiomyopathy and optic atrophy associated with a homozygous OPA1 mutation","volume":"53","author":"Spiegel","year":"2016","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.mito.2017.10.003_bb0640","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1002\/ajmg.a.36000","article-title":"Severe infantile leigh syndrome associated with a rare mitochondrial ND6 mutation, m.14487T>C","volume":"161A","author":"Tarnopolsky","year":"2013","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.mito.2017.10.003_bb0645","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1752-8062.2011.00357.x","article-title":"Alterations in skeletal muscle indicators of mitochondrial structure and biogenesis in patients with type 2 diabetes and heart failure: effects of epicatechin rich cocoa","volume":"5","author":"Taub","year":"2012","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.mito.2017.10.003_bb0650","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1039\/C6FO00611F","article-title":"Beneficial effects of dark chocolate on exercise capacity in sedentary subjects: underlying mechanisms. A double blind, randomized, placebo controlled trial","volume":"7","author":"Taub","year":"2016","journal-title":"Food Funct."},{"key":"10.1016\/j.mito.2017.10.003_bb0655","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1136\/jnnp-2013-306387","article-title":"Novel C12orf65 mutations in patients with axonal neuropathy and optic atrophy","volume":"85","author":"Tucci","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.mito.2017.10.003_bb0660","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ymgme.2010.04.010","article-title":"Long-term survival of neonatal mitochondrial complex III deficiency associated with a novel BCS1L gene mutation","volume":"100","author":"Tuppen","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.mito.2017.10.003_bb0665","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.2174\/138161282035140911142118","article-title":"Mitochondrial biogenesis: pharmacological approaches","volume":"20","author":"Valero","year":"2014","journal-title":"Curr. Pharm. Des."},{"issue":"6","key":"10.1016\/j.mito.2017.10.003_bb0670","doi-asserted-by":"crossref","first-page":"e21347","DOI":"10.1371\/journal.pone.0021347","article-title":"Mitochondrial oxidative phosphorylation compensation may preserve vision in patients with OPA1-linked autosomal dominant optic atrophy","volume":"6","author":"Van Bergen","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.mito.2017.10.003_bb0675","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/00041327-200303000-00057","article-title":"Optic nerve and chiasmal enhancement in Leber hereditary optic neuropathy","volume":"23","author":"Vaphiades","year":"2003","journal-title":"J. Neuroophthalmol."},{"key":"10.1016\/j.mito.2017.10.003_bb0680","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1167\/iovs.06-0331","article-title":"Male prevalence of acquired color vision defects in a symptomatic carriers of Leber\u2019s hereditary optic neuropathy","volume":"48","author":"Ventura","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.mito.2017.10.003_bb0685","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1007\/s00415-008-0926-3","article-title":"Novel twinkle (PEO1) gene mutations in mendelian progressive external ophthalmoplegia","volume":"255","author":"Virgilio","year":"2008","journal-title":"J. Neurol."},{"key":"10.1016\/j.mito.2017.10.003_bb0690","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/NRL.0000000000000084","article-title":"Mitochondrial encephalopathy and optic neuropathy due to m.10158 MT-ND3 complex I mutation presenting in an adult patient: case report and review of the literature","volume":"21","author":"Vodopivec","year":"2016","journal-title":"Neurologist"},{"key":"10.1016\/j.mito.2017.10.003_bb0695","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1136\/jmg.35.10.793","article-title":"Clinical features, molecular genetics, and pathophysiology of dominant optic atrophy","volume":"35","author":"Votruba","year":"1998","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.mito.2017.10.003_bb0700","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.cub.2012.04.054","article-title":"Optic atrophy 1-dependent mitochondrial remodeling controls steroidogenesis in trophoblasts","volume":"22","author":"Wasilewski","year":"2012","journal-title":"Curr. Biol."},{"key":"10.1016\/j.mito.2017.10.003_bb0705","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jns.2005.11.003","article-title":"Leber's hereditary optic neuropathy with dystonia in a Japanese family","volume":"243","author":"Watanabe","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.mito.2017.10.003_bb0710","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.mito.2013.09.004","article-title":"New mutation in MT-ND1 m.3928G>C p.V208L causes Leigh disease with infantile spasms","volume":"13","author":"Wray","year":"2013","journal-title":"Mitochondrion"},{"key":"10.1016\/j.mito.2017.10.003_bb0715","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ebiom.2016.07.002","article-title":"Long-term outcomes of gene therapy for the treatment of Leber's hereditary optic neuropathy","volume":"10","author":"Yang","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.mito.2017.10.003_bb0720","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.mito.2017.05.005","article-title":"Identification of FASTKD2 compound heterozygous mutations as the underlying cause of autosomal recessive MELAS with seizure","volume":"35","author":"Yoo","year":"2017","journal-title":"Mitochondrion"},{"issue":"10","key":"10.1016\/j.mito.2017.10.003_bb0725","doi-asserted-by":"crossref","first-page":"e13426","DOI":"10.1371\/journal.pone.0013426","article-title":"Mitochondrial DNA sequence variation and haplogroup distribution in Chinese patients with LHON and m.14484T>C","volume":"5","author":"Yu","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.mito.2017.10.003_bb0730","doi-asserted-by":"crossref","first-page":"e1238","DOI":"10.1073\/pnas.1119577109","article-title":"Gene delivery to mitochondria by targeting modified adenoassociated virus suppresses Leber's hereditary optic neuropathy in a mouse model","volume":"109","author":"Yu","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mito.2017.10.003_bb0735","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/brain\/awq007","article-title":"Multi-system neurological disease is common in patients with OPA1 mutations","volume":"133","author":"Yu-Wai-Man","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.mito.2017.10.003_bb0740","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1093\/hmg\/ddq209","article-title":"OPA1 mutations cause cytochrome c oxidase deficiency due to loss of wild-type mtDNA molecules","volume":"19","author":"Yu-Wai-Man","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mito.2017.10.003_bb0745","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.preteyeres.2010.11.002","article-title":"Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies","volume":"30","author":"Yu-Wai-Man","year":"2011","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.mito.2017.10.003_bb0750","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/eye.2014.37","article-title":"Treatment strategies for inherited optic neuropathies: past, present and future","volume":"28","author":"Yu-Wai-Man","year":"2014","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.mito.2017.10.003_bb0755","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1086\/346066","article-title":"The epidemiology of Leber hereditary optic neuropathy in the North East of England","volume":"72","author":"Y-W-Man","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.mito.2017.10.003_bb0760","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/brain\/awm335","article-title":"OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion","volume":"131","author":"Zanna","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.mito.2017.10.003_bb0765","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.bbrc.2009.06.051","article-title":"Mitochondrial DNA mutation m.3635G>A may be associated with Leber hereditary optic neuropathy in Chinese","volume":"386","author":"Zhang","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"10.1016\/j.mito.2017.10.003_bb0770","doi-asserted-by":"crossref","first-page":"e27750","DOI":"10.1371\/journal.pone.0027750","article-title":"Mitochondrial DNA haplogroup background affects LHON, but not suspected LHON, in Chinese patients","volume":"6","author":"Zhang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.mito.2017.10.003_bb0775","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.bbrc.2012.02.073","article-title":"A novel OPA1 mutation in a Chinese family with autosomal dominant optic atrophy","volume":"419","author":"Zhang","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mito.2017.10.003_bb0780","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1479-5876-10-43","article-title":"Mitochondrial DNA mutation m.10680G>A is associated with Leber hereditary optic neuropathy in Chinese patients","volume":"10","author":"Zhang","year":"2012","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.mito.2017.10.003_bb0785","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.mito.2014.08.008","article-title":"Leber's hereditary optic neuropathy caused by the homoplasmic ND1 m.3635G>A mutation in nine Han Chinese families","volume":"18","author":"Zhang","year":"2014","journal-title":"Mitochondrion"},{"key":"10.1016\/j.mito.2017.10.003_bb0790","first-page":"198","article-title":"Identification of mitochondrial DNA ND1 T3866C mutation in three ethnic Han Chinese families affected with Leber's hereditary optic neuropathy","volume":"32","author":"Zhang","year":"2015","journal-title":"Zhonghua Yi Xue Yi Chuan Xue Za Zhi"},{"key":"10.1016\/j.mito.2017.10.003_bb0795","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1007\/s12035-016-9771-z","article-title":"The OPA1 gene mutations are frequent in Han Chinese patients with suspected optic neuropathy","volume":"54","author":"Zhang","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.mito.2017.10.003_bb0800","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.neuroscience.2014.12.039","article-title":"Altered iPSC-derived neurons' sodium channel properties in subjects with Monge's disease","volume":"288","author":"Zhao","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.mito.2017.10.003_bb0805","doi-asserted-by":"crossref","first-page":"259","DOI":"10.4103\/0366-6999.174491","article-title":"A mitochondrial DNA A8701G mutation associated with maternally inherited hypertension and dilated cardiomyopathy in a Chinese pedigree of a consanguineous marriage","volume":"129","author":"Zhu","year":"2016","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.mito.2017.10.003_bb0810","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.bbrc.2010.07.051","article-title":"The MT-ND1 and MT-ND5 genes are mutational hotspots for Chinese families with clinical features of LHON but lacking the three primary mutations","volume":"399","author":"Zou","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Mitochondrion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567724917300223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567724917300223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T20:07:44Z","timestamp":1536264464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567724917300223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":161,"alternative-id":["S1567724917300223"],"URL":"https:\/\/doi.org\/10.1016\/j.mito.2017.10.003","relation":{},"ISSN":["1567-7249"],"issn-type":[{"value":"1567-7249","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondrial disorders of the retinal ganglion cells and the optic nerve","name":"articletitle","label":"Article Title"},{"value":"Mitochondrion","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mito.2017.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. and Mitochondria Research Society. All rights reserved.","name":"copyright","label":"Copyright"}]}}